Initial approval given in US for SangStat drug
SangStat, a Californian transplant specialist, won the first US regulatory approval for a generic version of cyclosporine, an immunosuppressant that helps prevent rejection of transplanted
SangStat, a Californian transplant specialist, won the first US regulatory approval for a generic version of cyclosporine, an immunosuppressant that helps prevent rejection of transplanted